Researchers continue to conduct studies to better understand whether GLP-1 drugs such as Ozempic, Wegovy, Trulicity and others (commonly used for diabetes and weight loss) may also lower cancer risk
This blog post intends to explore the realm of toxicology studies in drug development and demystify the FDA guidelines that govern these studies helping you to understand the FDA guidelines for toxicity studies
Wei Y, Mojsov S: Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences
Ruggenenti P, Cattaneo D, Loriga G, Ledda F, Motterlini N, Gherardi G, et al
Mechanisms of action of non-enzymatic antioxidants to control oxidative stress during in vitro follicle growth, oocyte maturation, and embryo development